A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL

Nagoya Medical Center, Nagoya

Japanese Red Cross Aichi Medical Center Nagoya Daini Hospital, Nagoya

National Cancer Center Hospital East, Kashiwa-shi

Kyushu Cancer Center, Fukuoka

Aso Iizuka Hospital, Iizuka-shi

Fukushima Medical University Hospital, Fukushima

Gifu Municipal Hospital, Gifu

Gunma Prefectural Cancer Center, Ota-shi

Hokkaido Cancer Center, Sapporo

Japanese Red Cross Society Himeji Hospital, Himeji-shi

Kanagawa Cancer Center, Yokohama

University Hospital, Kyoto Prefectural University of Medicine, Kyoto

Tohoku University Hospital, Sendai

Shinshu University Hospital, Matsumoto-shi

Japanese Red Cross Nagasaki Genbaku Hospital, Nagasaki

Osaka Saiseikai Nakatsu Hospital, Osaka

Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-kofukai, Osaka

Shimane University Hospital, Izumo-shi

Tokyo Metropolitan Komagome Hospital, Bunkyo-ku

National Cancer Center Hospital, Chuo-ku

Cancer Institute Hospital of JFCR, Koto-ku

Disaster Medical Center, Tachikawa-shi

Yamagata University Hospital, Yamagata